135 related articles for article (PubMed ID: 34522028)
1. The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme.
Urban-Wójciuk Z; Graham A; Barker K; Kwok C; Sbirkov Y; Howell L; Campbell J; Woster PM; Poon E; Petrie K; Chesler L
Cancer Gene Ther; 2022 Jul; 29(7):940-950. PubMed ID: 34522028
[TBL] [Abstract][Full Text] [Related]
2. Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.
Rounbehler RJ; Li W; Hall MA; Yang C; Fallahi M; Cleveland JL
Cancer Res; 2009 Jan; 69(2):547-53. PubMed ID: 19147568
[TBL] [Abstract][Full Text] [Related]
3. ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
Hogarty MD; Norris MD; Davis K; Liu X; Evageliou NF; Hayes CS; Pawel B; Guo R; Zhao H; Sekyere E; Keating J; Thomas W; Cheng NC; Murray J; Smith J; Sutton R; Venn N; London WB; Buxton A; Gilmour SK; Marshall GM; Haber M
Cancer Res; 2008 Dec; 68(23):9735-45. PubMed ID: 19047152
[TBL] [Abstract][Full Text] [Related]
4. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
[TBL] [Abstract][Full Text] [Related]
5. Polyamine-independent Expression of Caenorhabditis elegans Antizyme.
Stegehake D; Kurosinski MA; Schürmann S; Daniel J; Lüersen K; Liebau E
J Biol Chem; 2015 Jul; 290(29):18090-18101. PubMed ID: 26032421
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.
Gamble LD; Purgato S; Murray J; Xiao L; Yu DMT; Hanssen KM; Giorgi FM; Carter DR; Gifford AJ; Valli E; Milazzo G; Kamili A; Mayoh C; Liu B; Eden G; Sarraf S; Allan S; Di Giacomo S; Flemming CL; Russell AJ; Cheung BB; Oberthuer A; London WB; Fischer M; Trahair TN; Fletcher JI; Marshall GM; Ziegler DS; Hogarty MD; Burns MR; Perini G; Norris MD; Haber M
Sci Transl Med; 2019 Jan; 11(477):. PubMed ID: 30700572
[TBL] [Abstract][Full Text] [Related]
7. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
[TBL] [Abstract][Full Text] [Related]
8. Polyamine sensing by nascent ornithine decarboxylase antizyme stimulates decoding of its mRNA.
Kurian L; Palanimurugan R; Gödderz D; Dohmen RJ
Nature; 2011 Sep; 477(7365):490-4. PubMed ID: 21900894
[TBL] [Abstract][Full Text] [Related]
9. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
10. DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma.
Koomoa DL; Geerts D; Lange I; Koster J; Pegg AE; Feith DJ; Bachmann AS
Int J Oncol; 2013 Apr; 42(4):1219-28. PubMed ID: 23440295
[TBL] [Abstract][Full Text] [Related]
11. Regulation of polyamine biosynthesis by antizyme and some recent developments relating the induction of polyamine biosynthesis to cell growth. Review.
Canellakis ES; Kyriakidis DA; Rinehart CA; Huang SC; Panagiotidis C; Fong WF
Biosci Rep; 1985 Mar; 5(3):189-204. PubMed ID: 3893559
[TBL] [Abstract][Full Text] [Related]
12. Hypusinated eIF5A Promotes Ribosomal Frameshifting during Decoding of ODC Antizyme mRNA in
Halwas K; Döring LM; Oehlert FV; Dohmen RJ
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361762
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of antizyme-mediated regulation of polyamine homeostasis.
Wu HY; Chen SF; Hsieh JY; Chou F; Wang YH; Lin WT; Lee PY; Yu YJ; Lin LY; Lin TS; Lin CL; Liu GY; Tzeng SR; Hung HC; Chan NL
Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11229-34. PubMed ID: 26305948
[TBL] [Abstract][Full Text] [Related]
14. The antizyme family for regulating polyamines.
Kahana C
J Biol Chem; 2018 Nov; 293(48):18730-18735. PubMed ID: 30355739
[TBL] [Abstract][Full Text] [Related]
15. Polyamine synthesis as a target of
Bachmann AS; Geerts D
J Biol Chem; 2018 Nov; 293(48):18757-18769. PubMed ID: 30404920
[TBL] [Abstract][Full Text] [Related]
16. Protein degradation, the main hub in the regulation of cellular polyamines.
Kahana C
Biochem J; 2016 Dec; 473(24):4551-4558. PubMed ID: 27941031
[TBL] [Abstract][Full Text] [Related]
17. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
Evageliou NF; Haber M; Vu A; Laetsch TW; Murray J; Gamble LD; Cheng NC; Liu K; Reese M; Corrigan KA; Ziegler DS; Webber H; Hayes CS; Pawel B; Marshall GM; Zhao H; Gilmour SK; Norris MD; Hogarty MD
Clin Cancer Res; 2016 Sep; 22(17):4391-404. PubMed ID: 27012811
[TBL] [Abstract][Full Text] [Related]
18. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
19. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
[TBL] [Abstract][Full Text] [Related]
20. Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels.
Satriano J; Matsufuji S; Murakami Y; Lortie MJ; Schwartz D; Kelly CJ; Hayashi S; Blantz RC
J Biol Chem; 1998 Jun; 273(25):15313-6. PubMed ID: 9624108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
